GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (FRA:SYAB) » Definitions » YoY EBITDA Growth

Synlab AG (FRA:SYAB) YoY EBITDA Growth : -7.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Synlab AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Synlab AG's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -7.00%.

Synlab AG's EBITDA per Share for the three months ended in Mar. 2024 was €0.64.


Synlab AG YoY EBITDA Growth Historical Data

The historical data trend for Synlab AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG YoY EBITDA Growth Chart

Synlab AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- 72.83 -30.49 -28.22

Synlab AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.81 -31.06 12.79 25.81 -7.00

Synlab AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Synlab AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(2.78-3.873)/ | 3.873 |
=-28.22 %

Synlab AG's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0.638-0.686)/ | 0.686 |
=-7.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synlab AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Synlab AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Synlab AG (FRA:SYAB) Business Description

Traded in Other Exchanges
Address
Moosacher Strasse 88, Augsburg, BY, DEU, 80809
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (FRA:SYAB) Headlines

No Headlines